1. Home
  2. GSUN vs XBIO Comparison

GSUN vs XBIO Comparison

Compare GSUN & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$1.14

Market Cap

10.7M

Sector

Real Estate

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.04

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
XBIO
Founded
1997
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
5.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GSUN
XBIO
Price
$1.14
$2.04
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
106.7K
35.9K
Earning Date
02-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,314,724.00
$2,858,935.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
526.22
13.30
52 Week Low
$0.98
$1.90
52 Week High
$5.25
$13.93

Technical Indicators

Market Signals
Indicator
GSUN
XBIO
Relative Strength Index (RSI) 36.42 33.30
Support Level $1.13 $1.95
Resistance Level $1.20 $2.29
Average True Range (ATR) 0.10 0.16
MACD 0.01 0.01
Stochastic Oscillator 25.00 13.52

Price Performance

Historical Comparison
GSUN
XBIO

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: